Aurobindo Pharma Ltd completes US FDA Inspection at its Unit VII

Aurobindo Pharma Ltd's Unit VII, an oral manufacturing facility situated at Jadcherla, Hyderabad, received an Establishment Inspection Report (EIR) mentioning the inspection a Voluntary Action Initiated (VAI) from the US FDA and with this inspection is concluded.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 571.05 as compared to the previous close of Rs. 556.80. The total number of shares traded during the day was 76858 in over 2536 trades.

The stock hit an intraday high of Rs. 572.25 and intraday low of 554.10. The net turnover during the day was Rs. 43301006.00.

Source : Equity Bulls

Keywords

AurobindoPharma EIR USFDA VAI Jadcherla